TerminatedPhase 2

Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma

Stopped: Low accrual.

United States2 participantsStarted 2007-01

Plain-language summary

The purpose of this trial is to evaluate proton beam radiation therapy as an alternative to external photon beam irradiation in children with retinoblastoma as a means of local tumor control and ocular retention.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Active or recurrent retinoblastoma patient eligible for treatment of external beam radiation therapy.
✓. A parent or guardian who can provide informed consent to a minor or child participant.
✓. No concurrent infection.
✓. No contraindication for repeated general anesthesia/sedation.

Exclusion criteria

✕. Inability to return for multiple examinations under anesthesia.
✕. Medical contraindication for exams under anesthesia/sedation.
✕. Unreliable follow-up.

What they're measuring

Rate of Local Control in the Globe at 12 Months

Timeframe: 12 months

Trial details

NCT IDNCT00432445

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-02

Results submitted2015-02-12

View on ClinicalTrials.gov More Retinoblastoma trials